Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jim Carmichael"'
Autor:
Jim Carmichael, Mary A. Rutherford, Lisa Story, Jo Hajnal, Laura McCabe, Holly Lovell, Jacqueline Matthews, Sophie Arulkumaran, Alison Ho, Alexia Egloff, Caroline L. Knight, Megan Byrne, Audrey Jacques, Andrew Shennan
Publikováno v:
Pediatric Radiology
Background Magnetic resonance imaging (MRI) examinations are increasingly used in antenatal clinical practice. Incidental findings are a recognized association with imaging and although in some circumstances their identification can alter management,
Autor:
Joseph R. Davidson, Maria Deprez, Jacqueline Matthew, Alena Uus, Anna L. David, Mary A. Rutherford, Alexia Egloff, Jim Carmichael, Paolo De Coppi, Iain Yardley
Publikováno v:
The Lancet. Childadolescent health. 5(6)
Summary This Review depicts the evolving role of MRI in the diagnosis and prognostication of anomalies of the fetal body, here including head and neck, thorax, abdomen and spine. A review of the current literature on the latest developments in antena
Autor:
Marina Easty, Jim Carmichael
Publikováno v:
Pediatric Radiology. 40:963-974
At Great Ormond Street Hospital we have the highest number of paediatric renal transplant patients in Europe, taking cases from across the United Kingdom and abroad. Our caseload includes many children with rare complicating medical problems and chro
Autor:
Jim Carmichael
Publikováno v:
Natural Gas. 14:19-22
Publikováno v:
Medical Radiology ISBN: 9783642111433
Growing bone is challenging, as bone structure, shape and size change continuously until skeletal maturity. The numerous normal variants of growth which may mimic pathology have been accurately described radiographically, but little is known on the a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78ead3b6a5f7136f79019c04ebd4e8cf
https://doi.org/10.1007/174_2011_167
https://doi.org/10.1007/174_2011_167
Autor:
Aaron Cranston, Jim Carmichael, Christine M. Chresta, Louise Unwin, Louise J. Jones, Charlotte Knights, Niall M. B. Martin, Mark J. O'Connor, Tim Avis, Aisling O'Shaughnessy, Lucy Riches, Victoria Dunham, Ramu Mangena, Alan Lau
Publikováno v:
Molecular Cancer Therapeutics. 8:A114-A114
Background: The oral PARP inhibitor olaparib (AZD2281, KU-0059436) has shown anti-tumor activity in patients with hereditary BRCA mutations and provides positive evidence for synthetic lethal approaches for the treatment of cancers with DNA repair de